Latest filings (excl ownership)
8-K
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
22 Mar 24
8-K
Departure of Directors or Certain Officers
14 Mar 24
424B5
Prospectus supplement for primary offering
1 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
8-K
Beyond Air® Reports Financial Results
16 Feb 24
10-Q
2024 Q3
Quarterly report
12 Feb 24
DEFA14A
Additional proxy soliciting materials
8 Feb 24
DEF 14A
Definitive proxy
26 Jan 24
S-8
Registration of securities for employees
20 Dec 23
8-K
Beyond Air® Reports Financial Results
17 Nov 23
10-Q
2024 Q2
Quarterly report
13 Nov 23
8-K
Beyond Air® and Getz Healthcare Enter Strategic Collaboration to
7 Sep 23
EFFECT
Notice of effectiveness
22 Aug 23
CORRESP
Correspondence with SEC
17 Aug 23
UPLOAD
Letter from SEC
17 Aug 23
8-K
Beyond Air® Reports Financial Results
14 Aug 23
S-3
Shelf registration
11 Aug 23
10-Q
2024 Q1
Quarterly report
10 Aug 23
D
$1.38 mm in equity / options / securities to be acquired, sold $1.38 mm, 2 investors
28 Jun 23
8-K
Beyond Air® Reports Financial Results
23 Jun 23
10-K
2023 FY
Annual report
22 Jun 23
8-K
Beyond Air® Secures up to $40 Million Debt Financing
20 Jun 23
8-K
Other Events
24 Mar 23
8-K
Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer
23 Mar 23
8-K
Departure of Directors or Certain Officers
13 Mar 23
S-8
Registration of securities for employees
17 Feb 23
8-K
Beyond Air® Reports Financial Results
13 Feb 23
10-Q
2023 Q3
Quarterly report
9 Feb 23
DEFA14A
Additional proxy soliciting materials
31 Jan 23
DEF 14A
Definitive proxy
27 Jan 23
8-K
Beyond Air® Reports Financial Results
14 Nov 22
10-Q
2023 Q2
Quarterly report
8 Nov 22
8-K
Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022
20 Oct 22
8-K
Changes in Registrant's Certifying Accountant
7 Oct 22
CT ORDER
Confidential treatment order
22 Sep 22
8-K
Other Events
23 Aug 22
8-K
Beyond Air® Reports Financial Results
15 Aug 22
10-Q
2023 Q1
Quarterly report
11 Aug 22
8-K
Departure of Directors or Certain Officers
5 Jul 22
8-K
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022
30 Jun 22
Latest ownership filings
4
Steven A. Lisi
21 Mar 24
4
Michael A. Gaul
21 Mar 24
4
Yoori Lee
21 Mar 24
4
Robert Carey
21 Mar 24
4
RON BENTSUR
21 Mar 24
4
Amir Avniel
21 Mar 24
4
Erick Lucera
21 Mar 24
4
William P Forbes
21 Mar 24
4
Douglas Quinton Larson
21 Mar 24
4
Steven A. Lisi
21 Mar 24
4
Robert Carey
21 Mar 24
4
Douglas Quinton Larson
21 Mar 24
SC 13G
BlackRock Inc.
7 Mar 24
SC 13G/A
Mosseri Marlio Charles
14 Feb 24
SC 13G
BlackRock Inc.
29 Jan 24
4
Amir Avniel
29 Dec 23
4
Jeff Lynn Myers
29 Dec 23
144
Notice of proposed sale of securities
29 Dec 23
4
Steven A. Lisi
19 Dec 23
4
Robert Carey
19 Dec 23
5
Robert Carey
14 Dec 23
4
Michael A. Gaul
17 Nov 23
4
Robert Carey
29 Aug 23
4
Robert Carey
22 Aug 23
4
Michael A. Gaul
5 Jul 23
4
Amir Avniel
3 Apr 23
4
William P Forbes
3 Apr 23
4
Michael A. Gaul
31 Mar 23
4
Yoori Lee
31 Mar 23
4
Robert Carey
31 Mar 23
4
Douglas Quinton Larson
31 Mar 23
4
Steven A. Lisi
31 Mar 23
4
Erick Lucera
31 Mar 23
4
William P Forbes
31 Mar 23
4
Robert Carey
30 Mar 23
4
Yoori Lee
29 Mar 23
4
Jeff Lynn Myers
28 Mar 23
3
Jeff Lynn Myers
28 Mar 23
4
Michael A. Gaul
27 Mar 23
4
Steven A. Lisi
21 Mar 23